Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Bradley Hill Holdings Continue Biotech Division Expansion

Abstract:
In a speech delivered to Investors recently in Singapore, James Elliot; a senior partner in Hong Kong-based Venture Capital Firm Bradley Hill Holdings Ltd announced plans to expand their successful Biotech/Life Sciences division.

Bradley Hill Holdings Continue Biotech Division Expansion

Hong Kong, China | Posted on December 3rd, 2008

Elliot, who has been with Bradley Hill for over 10 years now, said that they would be utilizing "a global network of established partners and affiliates to keep our finger on the pulse of Research and Development in the Biotechnology field."

Bradley Hill Holdings are believed to be involved with a select number of hand-picked startup enterprises who have what the firm's associates say are "FDA-Approval failsafes". The common focus of these enterprises is said to be nanotechnology - with a particular eye on products being offered to the ever-growing medical services sector. Indeed, with the baby-boomer trend causing an ever-increasing average age in humans, this strategy is seen by many to be another example of Bradley Hill showing a level of forward thinking that sets top-tier VC firms apart from the crowd.

Little is known of Bradley Hill Holdings current projects, due to stringent non-disclosure agreements which are put in place to protect the integrity of their clients, as yet unpatented products and technologies, but they are well known for their private funding of many successful startups, as well as proving business development and go-to-market planning skills to firms who are often comprised of primarily academic & scientific minds.

####

About Bradley Hill Holdings Ltd
Bradley Hill Holdings were formed in 1981 and have been growing constantly since their formation, due in no large part to a handful of successful partnerships with dot-com wonderkids of the early-nineties and more recently, far-eastern biotech gurus, who have then gone on to sell out to industry kingpins such as GSK and Pfizer for astronomical gains.

Copyright © Bradley Hill Holdings Ltd

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

UNAM develops successful nano edible coating which increases life food September 27th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Carbodeon Ltd Oy Closes EUR 1.5 million Funding Round From Straightforward Capital: Carbodeon will accelerate its nanodiamonds business and expand manufacturing capacity August 21st, 2016

Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016

Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016

NanoLabNL boosts quality of research facilities as Dutch Toekomstfonds invests firmly June 10th, 2016

Nanomedicine

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

Tattoo therapy could ease chronic disease: Rice-made nanoparticles tested at Baylor College of Medicine may help control autoimmune diseases September 23rd, 2016

BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays September 20th, 2016

Announcements

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Fighting cancer with sticky nanoparticles September 27th, 2016

Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016

UNAM develops successful nano edible coating which increases life food September 27th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic